Targeted next-generation DNA sequencing of the 9 de novo RRD glioblastomas revealed a unique genomic landscape compared to the other 450 conventional IDH-wildtype glioblastomas (Fig. 2, Table 2, Supplementary Tables S3 and S4). The gene discussed is IDH2; the disease is glioblastoma.